TY - JOUR
T1 - County-level radon exposure and all-cause mortality risk among Medicare beneficiaries
AU - Yitshak-Sade, Maayan
AU - Blomberg, Annelise J.
AU - Zanobetti, Antonella
AU - Schwartz, Joel D.
AU - Coull, Brent A.
AU - Kloog, Itai
AU - Dominici, Francesca
AU - Koutrakis, Petros
N1 - Funding Information:
This publication was made possible by U.S. EPA grant numbers RD-834798 and RD-835872. Its contents are solely the responsibility of the grantee and do not necessarily represent the official views of the U.S. EPA. Further, U.S. EPA does not endorse the purchase of any commercial products or services mentioned in the publication. Research reported in this publication was also supported by the Office of the Director of the National Institutes of Health under Award Number DP5OD021412 , and by NIEHS R01 ES019853 , R01 ES024332 and NIH/NIEHS 3P30ES000002-53S3 .
Publisher Copyright:
© 2019 The Authors
PY - 2019/9/1
Y1 - 2019/9/1
N2 - Background: Radon is an inert gas formed from the decay of naturally-occurring materials in the earth's crust. It infiltrates into homes from soil, water, and construction materials. Its decay products are radionuclides, which attach to ambient particles. Residential radon is one of the leading risk factors for lung cancer. The scarce evidence for associations with other mortality causes originates mostly from occupational studies. Methods: In a cohort study with 14 years of follow-up (2000−2013), we evaluated the association between chronic radon exposure and all-cause mortality, and explored whether there are subpopulations who are more vulnerable to radon effects. We included 87,296,195 person-years of follow-up from all Medicare beneficiaries in the Mid-Atlantic and Northeastern U.S. states. We examined the association between the logarithm of county-averaged radon (ln(Rn)) and mortality and assessed effect modification by chronic conditions. Results: An interquartile range increase in the ln(Rn) was associated with a 2·62% increase (95% CI 2·52%; 2·73%) in mortality, independent of PM2.5 exposure. Larger mortality risks were observed among individuals with respiratory, cardiovascular and metabolic diseases, with the highest associations observed among those with diabetes (4·98% increase), heart failure (4·58% increase), and chronic obstructive pulmonary disease (4·49% increase). Conclusion: We found an increased risk for all-cause mortality associated with increased radon exposure. The risk was enhanced among susceptible individuals with chronic conditions. We believe this is the first cohort study to identify populations at higher risk for non-malignant health consequences of radon exposure. Due to the limitations in exposure assessment and availability of individual confounders, these findings should be interpreted with caution.
AB - Background: Radon is an inert gas formed from the decay of naturally-occurring materials in the earth's crust. It infiltrates into homes from soil, water, and construction materials. Its decay products are radionuclides, which attach to ambient particles. Residential radon is one of the leading risk factors for lung cancer. The scarce evidence for associations with other mortality causes originates mostly from occupational studies. Methods: In a cohort study with 14 years of follow-up (2000−2013), we evaluated the association between chronic radon exposure and all-cause mortality, and explored whether there are subpopulations who are more vulnerable to radon effects. We included 87,296,195 person-years of follow-up from all Medicare beneficiaries in the Mid-Atlantic and Northeastern U.S. states. We examined the association between the logarithm of county-averaged radon (ln(Rn)) and mortality and assessed effect modification by chronic conditions. Results: An interquartile range increase in the ln(Rn) was associated with a 2·62% increase (95% CI 2·52%; 2·73%) in mortality, independent of PM2.5 exposure. Larger mortality risks were observed among individuals with respiratory, cardiovascular and metabolic diseases, with the highest associations observed among those with diabetes (4·98% increase), heart failure (4·58% increase), and chronic obstructive pulmonary disease (4·49% increase). Conclusion: We found an increased risk for all-cause mortality associated with increased radon exposure. The risk was enhanced among susceptible individuals with chronic conditions. We believe this is the first cohort study to identify populations at higher risk for non-malignant health consequences of radon exposure. Due to the limitations in exposure assessment and availability of individual confounders, these findings should be interpreted with caution.
KW - Mortality
KW - PM
KW - Radiation
KW - Radon
UR - http://www.scopus.com/inward/record.url?scp=85066985365&partnerID=8YFLogxK
U2 - 10.1016/j.envint.2019.05.059
DO - 10.1016/j.envint.2019.05.059
M3 - Article
AN - SCOPUS:85066985365
SN - 0160-4120
VL - 130
JO - Environment international
JF - Environment international
M1 - 104865
ER -